A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder
Clinical trial NCT06126653 · COMPLETED
Trial details
- NCT number
- NCT06126653
- Sponsor
- Aardvark Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-01-13
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.